ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| 1 |
Teladoc Health
TDOC
|
$1.16B |
| 2 |
Exact Sciences
EXAS
|
$634M |
| 3 |
PayPal
PYPL
|
$553M |
| 4 |
Shopify
SHOP
|
$544M |
| 5 |
Tesla
TSLA
|
$496M |
Top Sells
| 1 |
WORK
Slack Technologies, Inc.
WORK
|
$546M |
| 2 |
Illumina
ILMN
|
$343M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
$233M |
| 4 |
Zscaler
ZS
|
$196M |
| 5 |
Editas Medicine
EDIT
|
$38.2M |
Sector Composition
| 1 | Healthcare | 32.82% |
| 2 | Technology | 23.96% |
| 3 | Communication Services | 14.69% |
| 4 | Consumer Discretionary | 10.63% |
| 5 | Financials | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Meta Platforms (Facebook)
META
$1.86T
| $179M | 0.48% | 654,316 -75,462 | -10% | -$20.6M |
|
52
Arcturus Therapeutics
ARCT
$462M
| $172M | 0.46% | 3,959,019 +1,463,177 | +59% | +$63.5M |
|
53
Snap
SNAP
$12.1B
| $166M | 0.44% | 3,323,503 +702,111 | +27% | +$35.2M |
|
54
Alphabet (Google) Class A
GOOGL
$2.57T
| $165M | 0.44% | +94,110 | New | +$165M |
|
55
Takeda Pharmaceutical
TAK
$47.3B
| $157M | 0.42% | 8,618,165 +7,461,868 | +645% | +$136M |
|
56
Incyte
INCY
$16.5B
| $155M | 0.41% | 1,782,380 +1,203,054 | +208% | +$105M |
|
57
JD.com
JD
$44.1B
| $144M | 0.38% | 1,637,783 +945,079 | +136% | +$83.1M |
|
58
Castle Biosciences
CSTL
$696M
| $139M | 0.37% | 2,068,592 +1,620,867 | +362% | +$109M |
|
59
Ionis Pharmaceuticals
IONS
$6.79B
| $136M | 0.36% | 2,399,554 +1,896,994 | +377% | +$107M |
|
|
CELL
60
DELISTED
PhenomeX Inc. Common Stock
CELL
| $131M | 0.35% | 1,464,517 +1,378,185 | +1,596% | +$123M |
|
61
Alibaba
BABA
$322B
| $125M | 0.33% | 537,424 +280,052 | +109% | +$65.2M |
|
62
Apple
AAPL
$3.45T
| $121M | 0.32% | 914,900 +684,976 | +298% | +$90.9M |
|
63
Netflix
NFLX
$513B
| $112M | 0.3% | 206,418 +121,979 | +144% | +$66M |
|
64
Schrodinger
SDGR
$1.44B
| $110M | 0.29% | 1,395,453 +878,418 | +170% | +$69.6M |
|
|
ACCD
65
DELISTED
Accolade, Inc. Common Stock
ACCD
| $103M | 0.27% | 2,368,304 +1,774,720 | +299% | +$77.2M |
|
66
Fastly
FSLY
$1.12B
| $99.5M | 0.26% | +1,138,656 | New | +$99.5M |
|
67
Salesforce
CRM
$245B
| $99.4M | 0.26% | 446,604 +301,960 | +209% | +$67.2M |
|
|
SYRS
68
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $98.1M | 0.26% | 9,041,321 -2,171,185 | -19% | -$23.6M |
|
69
NVIDIA
NVDA
$4.24T
| $95.4M | 0.25% | 182,606 +95,342 | +109% | +$49.8M |
|
70
Beam Therapeutics
BEAM
$1.66B
| $92.4M | 0.25% | +1,131,623 | New | +$92.4M |
|
71
Adaptive Biotechnologies
ADPT
$2.01B
| $91.4M | 0.24% | 1,545,703 +660,981 | +75% | +$39.1M |
|
72
Opendoor
OPEN
$3.27B
| $90.9M | 0.24% | 4,001,226 +3,801,511 | +1,903% | +$86.4M |
|
73
Thermo Fisher Scientific
TMO
$186B
| $88.6M | 0.24% | 190,269 +190,192 | +247,003% | +$88.6M |
|
74
Codexis
CDXS
$246M
| $86.5M | 0.23% | 3,962,106 +2,549,807 | +181% | +$55.7M |
|
75
Veeva Systems
VEEV
$44B
| $82.4M | 0.22% | +302,629 | New | +$82.4M |
|